Last $51.59 USD
Change Today 0.00 / 0.00%
Volume 0.0
CHGCY On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
OTC US
Frankfurt
As of 8:10 PM 04/7/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for chugai pharmaceutic-unsp adr (CHGCY)

Year over year, Chugai Pharmaceutical Co. Ltd. has seen revenues remain relatively flat (¥391.2B JPY to ¥401.3B JPY), though the company was able to grow net income from ¥48.2B JPY to ¥50.9B JPY. A reduction in the percentage of sales devoted to selling, general and administrative costs from 23.51% to 20.85% was a key component in the bottom line growth in the face of flat revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Dec 31
2010
JPY
Dec 31
2011
JPY
Dec 31
2012
JPY
Dec 31
2013
JPY
4 Year
Trend
Revenues375,560.0363,622.0391,220.0401,298.0
Other Revenues3,950.09,895.0--22,354.0
TOTAL REVENUES379,510.0373,517.0391,220.0423,652.0
Cost of Goods Sold162,418.0157,507.0167,726.0186,977.0
GROSS PROFIT217,092.0216,010.0223,494.0236,675.0
Selling General & Admin Expenses, Total96,151.097,723.091,973.083,657.0
R&D Expenses54,703.055,857.055,107.074,280.0
OTHER OPERATING EXPENSES, TOTAL150,854.0153,580.0147,080.0157,937.0
OPERATING INCOME66,238.062,430.076,414.078,738.0
Interest Expense-4.0-4.0-4.0-12.0
Interest and Investment Income450.0842.0478.0--
NET INTEREST EXPENSE446.0838.0474.0-12.0
Currency Exchange Gains (Loss)-1,885.0532.0-3,196.0--
Other Non-Operating Income (Expenses)549.0-848.0732.0-1,782.0
EBT, EXCLUDING UNUSUAL ITEMS65,348.062,952.074,424.076,944.0
Merger & Restructuring Charges480.0-69.0----
Gain (Loss) on Sale of Investments91.0-217.0-4.0--
Gain (Loss) on Sale of Assets-192.0-667.0-354.0--
Other Unusual Items, Total-41.0-4,868.01,255.0--
Other Unusual Items---4,723.035.0--
EBT, INCLUDING UNUSUAL ITEMS65,686.057,131.075,321.076,944.0
Income Tax Expense23,096.020,856.026,330.025,058.0
Minority Interest in Earnings-1,157.0-1,040.0-786.0-991.0
Earnings from Continuing Operations42,590.036,275.048,991.051,886.0
NET INCOME41,433.035,235.048,205.050,895.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS41,433.035,235.048,205.050,895.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS41,433.035,235.048,205.050,895.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHGCY:US $51.59 USD 0.00

CHGCY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amgen Inc $115.54 USD +0.54
Genmab A/S kr192.00 DKK +9.00
ImmunoGen Inc $14.21 USD +1.41
Novartis AG SFr.74.10 CHF -0.25
Spectrum Pharmaceuticals Inc $6.88 USD +0.18
View Industry Companies
 

Industry Analysis

CHGCY

Industry Average

Valuation CHGCY Industry Range
Price/Earnings 27.4x
Price/Sales 3.3x
Price/Book 2.4x
Price/Cash Flow 28.2x
TEV/Sales 2.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHUGAI PHARMACEUTIC-UNSP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.